CAR-T therapy for endocrine neoplasms: novel targets and combination of therapies

CAR-T therapy for endocrine neoplasms: novel targets and combination of therapies

Endocrine malignancies constitute a heterogeneous tumour group with diverse biological characteristics. While typically indolent, they encompass aggressive types and presence of any metastatic sign indicates a high probability of recurrence and a diminished response to conventional therapies. Chimer...

Full description

Saved in:
Bibliographic Details
Main Authors: Fang Wang, Ruiqi Zhang, Zhaokai Zhou, Run Shi, Fu Peng, Yudi Xu, Shuai Yang, Zhan Wang, Pengpeng Zhang, Rui Tu, Chun Zhang, Xingchen Liu, Jun Cai
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Endocrinology
Subjects:
endocrine neoplasms
chimeric antigen receptor T cell
immunotherapy
combined immunotherapy
clinical trials
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2025.1517525/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2025.1517525/full

Similar Items